DAX23.745 ±0,0%ESt505.513 +0,2%Top 10 Crypto15,75 +2,8%Dow46.243 ±-0,0%Nas22.680 +0,9%Bitcoin97.148 +1,4%Euro1,1736 +0,4%Öl68,30 -2,1%Gold3.826 +1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA RENK RENK73 Lufthansa 823212 NVIDIA 918422 Novo Nordisk A3EU6F HENSOLDT HAG000 Tesla A1CX3T Siemens Energy ENER6Y BYD A0M4W9 Deutsche Telekom 555750 Mercedes-Benz Group (ex Daimler) 710000 SAP 716460 BASF BASF11 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX wenig bewegt -- US-Börsen uneins -- Lufthansa: Restrukturierung und drohende Streiks -- Palantir, Intel, Canopy Growth, D-Wave & Co., Novo Nordisk, Occidental, DroneShield, BYD im Fokus
Top News
EU-weite Krypto-Lizenzen in Gefahr? Frankreich prüft Einschränkungen EU-weite Krypto-Lizenzen in Gefahr? Frankreich prüft Einschränkungen
Stellantis-Aktie sinkt leicht: Joao Laranjo wird neuer Finanzchef Stellantis-Aktie sinkt leicht: Joao Laranjo wird neuer Finanzchef
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

ImmunityBio Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
2,14 EUR -0,01 EUR -0,33 %
FSE
2,56 USD +0,02 USD +0,59 %
BTT
ImmunityBio jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.2,05 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2QQ2E

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS45256X1037

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolIBRX

ImmunityBio Aktien News

DatumMeistgelesen
BenzingaWhat's Going On With ImmunityBio Shares Tuesday?
ZacksImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
ZacksImmunityBio (IBRX) Moves to Buy: Rationale Behind the Upgrade
Wer­bungImmunityBio-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
ZacksImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates
BenzingaImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug
ZacksImmunityBio (IBRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
BenzingaImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug
ZacksImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates
BenzingaIonQ, H&E Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
BenzingaImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details
BenzingaWhat's Going On With ImmunityBio Shares Wednesday?
PR NewswireImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment
ZacksWall Street Analysts Think ImmunityBio (IBRX) Could Surge 184.43%: Read This Before Placing a Bet
PR NewswireImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements
ZacksImmunityBio (IBRX) Reports Q3 Loss, Tops Revenue Estimates
ZacksImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?
BenzingaTrump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
Benzinga800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
PR NewswireIMMUNITYBIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX
PR NewswireSHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. (IBRX) Shareholders
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX
PR NewswireIBRX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. Shareholders
PR NewswireROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX
PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating ImmunityBio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR NewswireIBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX
PR NewswireIBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit
PR NewswireIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio Shareholders of a Lead Plaintiff Deadline of August 29, 2023
PR NewswireIBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX
PR NewswireIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio Shareholders of a Lead Plaintiff Deadline of August 29, 2023
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX
PR NewswireCalling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX

ImmunityBio News

ImmunityBio News: auf dieser Seite finden Sie alle ImmunityBio News und Nachrichten zur ImmunityBio Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch ImmunityBio News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um ImmunityBio News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.